Cargando…
RNA in Therapeutics: CRISPR in the Clinic
The advent of the CRISPR-Cas genome editing platform has greatly enhanced the capabilities of researchers in many areas of biology. Its use has also been turned to the development of therapies for genetic diseases and to the enhancement of cell therapies. This review describes some recent advances i...
Autor principal: | Carroll, Dana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880604/ https://www.ncbi.nlm.nih.gov/pubmed/36482771 http://dx.doi.org/10.14348/molcells.2022.0163 |
Ejemplares similares
-
Keeping crispr in check: diverse mechanisms of phage-encoded anti-crisprs
por: Trasanidou, Despoina, et al.
Publicado: (2019) -
The therapeutic potential of RNA interference
por: Uprichard, Susan L.
Publicado: (2005) -
Development of clustered regularly interspaced short palindromic repeats/CRISPR-associated technology for potential clinical applications
por: Huang, Yue-Ying, et al.
Publicado: (2022) -
Recent Advances in CRISPR-Cas Technologies for Synthetic Biology
por: Jeong, Song Hee, et al.
Publicado: (2023) -
Multiplex genome editing of microorganisms using CRISPR-Cas
por: Adiego-Pérez, Belén, et al.
Publicado: (2019)